Wang Wen, Dong Jing, Wang Maoxiu, Yao Shujuan, Tian Xiangyu, Cui Xiujuan, Fu Shijie, Zhang Shiqian
Department of Obstetrics and Gynecology, Jining Medical University Affiliated Tengzhou Central People's Hospital, Tengzhou, Shandong 277599, P.R. China.
Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China.
Oncol Lett. 2018 May;15(5):6131-6136. doi: 10.3892/ol.2018.8110. Epub 2018 Feb 23.
MicroRNAs (miRNAs) are a group of small non-coding RNAs that modulate post-transcriptional gene expression. It has been demonstrated that various miRNAs may be expressed at different levels in different types of tumors. The present study assessed the role of microRNA-148a-3p (miR-148a-3p) in epithelial ovarian cancer (EOC). The results demonstrated that miR-148a-3p was decreased in EOC tissues and that a lower miRa-148-3p concentration was associated with a higher overall survival rate. Transfection of miR-148a-3p suppressed the invasive and proliferative capacity of SKOV3 cells. The induced overexpression of miR-148a-3p significantly inhibited the relative luciferase activity of the pmirGLO-c-Met-3'untranslated region compared with an empty vector. In addition, c-Met silencing led to a decrease in the invasive and proliferative capacity of EOC cells. The inhibition of miR-148a-3p did not increase the invasiveness of SKOV3 cells, even when c-Met was silenced. To the best of our knowledge, the present study is the first to demonstrate that miR-148a-3p expression is decreased in EOC cancer tissues and cell lines. The present study therefore demonstrated that miR-148a-3p may serve as a tumor suppressor in EOC by targeting c-Met.
微小RNA(miRNA)是一类可调节转录后基因表达的小型非编码RNA。业已证明,不同类型的肿瘤中各种miRNA的表达水平可能不同。本研究评估了微小RNA-148a-3p(miR-148a-3p)在上皮性卵巢癌(EOC)中的作用。结果表明,EOC组织中miR-148a-3p表达降低,且miR-148a-3p浓度较低与较高的总生存率相关。转染miR-148a-3p可抑制SKOV3细胞的侵袭和增殖能力。与空载体相比,miR-148a-3p的诱导过表达显著抑制了pmirGLO-c-Met-3'非翻译区的相对荧光素酶活性。此外,c-Met沉默导致EOC细胞的侵袭和增殖能力下降。即使c-Met沉默,miR-148a-3p的抑制也不会增加SKOV3细胞的侵袭性。据我们所知,本研究首次证明EOC癌组织和细胞系中miR-148a-3p表达降低。因此,本研究表明miR-148a-3p可能通过靶向c-Met在上皮性卵巢癌中发挥肿瘤抑制作用。